Anúncio
Anúncio

SAVA

SAVA logo

Cassava Sciences, Inc.

2.19
USD
Patrocinado
+0.06
+3.07%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

2.19

0.00
0.00%

Relatórios de Lucros SAVA

Rácio de surpresa positiva

SAVA separação 19 de 29 últimas estimativas.

66%

Próximo Relatório

Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.30
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+36.36%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-46.43%

Cassava Sciences, Inc. earnings per share and revenue

On 12 de nov. de 2025, SAVA reported earnings of -0.22 USD per share (EPS) for Q3 25, beating the estimate of -0.27 USD, resulting in a 20.12% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an aumentar of 36.36% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Cassava Sciences, Inc. reported EPS of -$0.22, beating estimates by 20.12%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.82%, changed from $3.11 before the earnings release to $3.26 the day after.
The next earning report is scheduled for 02 de mar. de 2026.
Based on 3 analistas, Cassava Sciences, Inc. is expected to report EPS of -$0.30 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio